Eight Creighton professors have received grants from the National Institute of Health totaling $3,093,572, including:
Peter Steyger, MD, professor of biomedical sciences, received an NIH R25 award in the amount of $1,010,122 for his project titled “Enhancing diverse graduate student opportunities in auditory and vestibular neuroscience.”
Patrick Swanson, PhD, professor of medical microbiology and immunology, received an NIH R21award in the amount of $382,200 for his project titled “Role of a RAG1-DCAF1(VprBP)-EZH2 axis in B cell development.”
Peter Steyger, MD, and Patrick Swanson, PhD, also received an NIH supplement award for $250,000.
Sudhanva Kashyap, PhD, assistant professor of medical microbiology and immunology, has been awarded a $410,000 grant from the National Institute of Health (NIH) and the National Institute of Allergy and Infectious Disease (NIAID) to combat human-parasitic infections. His goal is to develop more effective treatment strategies and ultimately eliminate neglected tropical diseases to improve the lives of more than 1 billion people worldwide. Read more about his study.
Justine Renauld, PhD, assistant professor of biomedical sciences, received an NIH R21 award of $551,250 for her project titled “Understanding the role of stress hormones in Meniere’s disease.”
Kimberley Scott, DPT, PhD, assistant professor of physical therapy; Anastasia Kyvelidou, PhD, associate professor and director of the Department of Physical Therapy; and Dimitrio Katsavelis, PhD, associate professor of exercise science and pre-health professions, received a $50,000 NIH grant from the National Pediatric Rehabilitation Center on defining intervention dose-response relationships: Using wearable to qualify upper extremity motor performance among infants with cerebral palsy.
Dustin Stairs, PhD, professor of psychological science, received a $440,000 award from the National Institutes of Health in August toward his project titled “The Developmental Effects of Environmental Enrichment on the Minor Cannabinoid Drug Reward and Cannabinoid Receptor Levels.”